News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cytos Biotechnology AG Aiming for Lucrative Asthma Drug Deal Worth $541 Million According to CEO



6/24/2010 11:26:37 AM

Reuters -- Swiss biotech company Cytos (CYTN.S) is aiming to clinch a partnering deal worth over 600 million Swiss francs ($541 million) for its asthma vaccine after strong mid-trial data, the group's head was quoted as saying.

Read at Reuters

Related News

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES